XTX Topco’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

XTX Topco’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-219,819	Closed	-$118K	–	3310
2024 Q4	$118K	Buy	219,819 +206,614	+1,565%	+$144K	0.01%	1731
2024 Q3	$23.2K	Sell	13,205 -184,735	-93%	-$258K	﹤0.01%	1818
2024 Q2	$232K	Buy	+197,940	New	+$495K	0.02%	1135
2023 Q1	–	Sell	-55,106	Closed	-$219K	–	1746
2022 Q4	$219K	Buy	55,106 +42,293	+330%	+$208K	0.05%	785
2022 Q3	$85K	Sell	12,813 -25,169	-66%	-$155K	0.02%	973
2022 Q2	$184K	Buy	+37,982	New	+$231K	0.08%	487

XTX Topco's MRNS Position: Q1 2025 in Review

XTX Topco sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 219,819 shares — an estimated $118K sold.

XTX Topco first reported a position in MRNS in Q2 2022 and held it in 6 quarters. The position peaked at $232K in Q2 2024. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

XTX Topco reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
XTX Topco sold 219,819 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $118K.
XTX Topco first reported a position in Marinus Pharmaceuticals, Inc in Q2 2022 and held it in 6 quarters.
XTX Topco's Marinus Pharmaceuticals, Inc position peaked at $232K in Q2 2024.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on XTX Topco's 13F filing for Q1 2025, filed 8 May 2025.